CARDIOSOLV™: A NEW PARADIGM FOR VT ABLATION
CardioSolv™ is an early stage company developing new strategies to improve the treatment of patients with Ventricular Tachycardia (VT), a life-threatening arrhythmia. Using proprietary software and algorithms, CardioSolv™ develops a patient-specific model that guides VT ablation therapy with the goal of improving patient outcomes while reducing procedure time and cost.
Company Details
- Founded
- -
- in****@****olv.com
- Industry
- Medical Device
- Website
- http://www.cardiosolv.com
Cardiosolv Ablation Technologies, Inc. Questions
Cardiosolv Ablation Technologies, Inc.'s website is http://www.cardiosolv.com
Cardiosolv Ablation Technologies, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cardiosolv-ablation-technologies-inc-
Cardiosolv Ablation Technologies, Inc.'s industry is
Medical Device
Cardiosolv Ablation Technologies, Inc.'s top competitors are
Atacor Medical, Inc.,
Enovis Latam,
Exostat Medical, Inc.,
Airecmo, Inc.,
Qr8 Health,
Enspire Dbs Therapy, Inc.,
Swiss Ablation,
Spline Medical,
Central Valley Perfusion, Inc,
Essenz.
Cardiosolv Ablation Technologies, Inc.'s support email address is info@cardiosolv.com
Cardiosolv Ablation Technologies, Inc.'s categories are Medical Device
Cardiosolv Ablation Technologies, Inc.'s founding year is 2012
